Protagonist Therapeutics, Inc.
NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS
Last updated:
Abstract:
The invention relates to thioether monomer and dimer peptide molecules which inhibit binding of .alpha.4.beta.7 to the mucosal addressing cell adhesion molecule (MAdCAM) in vivo.
Status:
Application
Type:
Utility
Filling date:
29 Dec 2020
Issue date:
2 Dec 2021